SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001094891-21-000212
Filing Date
2021-05-25
Accepted
2021-05-25 21:17:34
Documents
1
Period of Report
2021-05-24

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 11168
  Complete submission text file 0001094891-21-000212.txt   13252
Mailing Address 1201 N. MARKET STREET SUITE 111 WILMINGTON DE 19801
Business Address 1201 N. MARKET STREET SUITE 111 WILMINGTON DE 19801 484-254-6134
NRX Pharmaceuticals, Inc. (Issuer) CIK: 0001719406 (see all company filings)

IRS No.: 822844431 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2645 N. FEDERAL HIGHWAY SUITE 230 DELRAY BEACH FL 33483
Business Address 2645 N. FEDERAL HIGHWAY SUITE 230 DELRAY BEACH FL 33483 3107342300
Big Rock Partners Sponsor, LLC (Reporting) CIK: 0001723217 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38302 | Film No.: 21962536

Mailing Address 2645 N. FEDERAL HIGHWAY SUITE 230 DELRAY BEACH FL 33483
Business Address
ACKERMAN RICHARD (Reporting) CIK: 0001724016 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38302 | Film No.: 21962535